All offering materials, financial projections, and company information for accredited investors. Strictly confidential.
Select View Online to open any document directly in your browser, or Download to save a local copy. Files are hosted at regenhealthmd.com.
Wellness Franchise Group captures revenue at every market segment — from high-velocity satellite clinics to full-scale wellness centers, with a luxury resort concept in development evaluation.
Management projections based on 7 operating locations at close, expanding to 55 locations by Year 5 across corporate, wellness center, and franchise units. Aethera hotel concept excluded from base case.
| Metric | Yr 1 · 2026 | Yr 2 · 2027 | Yr 3 · 2028 | Yr 4 · 2029 | Yr 5 · 2030 |
|---|---|---|---|---|---|
| Total Locations | 7 | 15 | 25 | 38 | 55 |
| Total Revenue | $3M | $6M | $12M | $28M | $52M |
| EBITDA | $1M | $2.1M | $4.5M | $11M | $21M |
| EBITDA Margin | 33% | 35% | 37.5% | 39% | 40% |
| Implied Valuation (10–15×) | — | — | $45M | $132M | $315M |
| Exit Target Range | — | $100M | $180M | ||
Capital deployed across three strategic buckets to maximize clinical scale, franchise infrastructure, and partner integration — including dedicated allocations to USMLE100 and Fulcrum Performance Labs.
A patented biometric monitoring platform embedded across WFG locations — creating a defensible data moat and clinical outcomes engine trusted by professional athletes.
WFG operates a rigorous, tripartite Institutional Review Board structure led by nationally recognized clinical and research experts — ensuring protocol integrity, physician training, and data credibility across all specialties. USMLE100 ($50K allocation) establishes and integrates these IRBs across the full platform.
Defined execution cadence from capital close through national franchise rollout and potential exit event.
Physician-led, operator-executed. A team combining clinical expertise, franchise experience, performance science, and medical education innovation.
